TRPC1 can be activated by CaSR in rabbit mesenteric arteries (14), colonic epithelial (15, 16), endothelial (17), and breast cancer cells (18), making it an ideal candidate for mediating the suppression of PTH secretion downstream of CaSR in the PTG. Here, CASR is linked to breast carcinoma.